All forms of dementia including Alzheimer’s disease are currently incurable. Mitochondrial dysfunction and calcium alterations are shown to be involved in the mechanism of neurodegeneration in Alzheimer’s disease. Previously we have described the ability of compound Tg-2112x to protect neurons via sequestration of mitochondrial calcium uptake and we suggest that it can also be protective against neurodegeneration and development of dementia. Using primary co-culture neurons and astrocytes we studied the effect of Tg-2112x and its derivative Tg-2113x on β-amyloid-induced changes in calcium signal, mitochondrial membrane potential, mitochondrial calcium, and cell death. We have found that both compounds had no effect on β-amyloid or acetylcholine-induced calcium changes in the cytosol although Tg2113x, but not Tg2112x reduced glutamate-induced calcium signal. Both compounds were able to reduce mitochondrial calcium uptake and protected cells against β-amyloid-induced mitochondrial depolarization and cell death. Behavioral effects of Tg-2113x on learning and memory in fear conditioning were also studied in 3 mouse models of neurodegeneration: aged (16-month-old) C57Bl/6j mice, scopolamine-induced amnesia (3-month-old mice), and 9-month-old 5xFAD mice. It was found that Tg-2113x prevented age-, scopolamine- and cerebral amyloidosis-induced decrease in fear conditioning. In addition, Tg-2113x restored fear extinction of aged mice. Thus, reduction of the mitochondrial calcium uptake protects neurons and astrocytes against β-amyloid-induced cell death and contributes to protection against dementia of different ethology. These compounds could be used as background for the developing of a novel generation of disease-modifying neuroprotective agents.
The evolution of man on Earth took place under conditions of constant exposure to background ionizing radiation (IR). From this point of view, it would be reasonable to hypothesize the existence of adaptive mechanisms that enable the human organism to safely interact with IR at levels approximating long-term natural background levels. In some situations, the successful operation of molecular mechanisms of protection against IR is observed at values significantly exceeding the natural background level, for example, in cancer cells. In 15–25% of cancer patients, cancer cells develop a phenotype that is resistant to high doses of IR. While further investigations are warranted, the current evidence suggests a strong probability of observing positive health effects, including an increased lifespan, a reduced cancer risk, and a decreased incidence of congenital pathologies, precisely at low doses of ionizing radiation. This review offers arguments primarily based on a phenomenological approach and critically reconsidering existing methodologies for assessing the biological risks of IR to human health. Currently, in the most economically developed countries, there are radiation safety rules that interpret low-dose radiation as a clearly negative environmental factor. Nowadays, this approach may pose significant challenges to the advancement of radiomedicine and introduce complexities in the regulation of IR sources. The review also examines molecular mechanisms that may play a key role in the formation of the positive effects of low-dose IR on human radioadaptive capabilities.
The IMD and Toll signaling pathways in Drosophila melanogaster mediate the innate immune responses to Gram-negative and Gram-positive bacteria and fungi, respectively. Here we studied the involvement of the NF-κB transcription factor Relish, which is a mediator of the IMD pathway, in the humoral immune response to the Gram-positive bacteria Micrococcus luteus and Bacillus subtilis and the entomopathogenic fungus Metarhizium anisopliae , using D. melanogaster S2 cells as a model. Activation of Relish proteolysis was observed after S2 cell treatment with the control Gram-negative bacterium Escherichia coli . We found that M. luteus had also a noticeable effect on Relish activation, while B. subtilis and M. anisopliae effects were modest. Activation patterns of the genes encoding predominantly the IMD-pathway-dependent antimicrobial peptides (AMPs) and peptidoglycan recognition proteins (PGRPs), as well as the levels of Relish recruitment to the promoters of the genes, were found to be very similar in S2 cells treated with E. coli or M. luteus but were lower and differed in the case of B. subtilis and M. anisopliae. A Relish knockdown (KD) decreased the induction levels observed for all AMP and some PGRP genes in response to M. luteus treatment and the induction levels observed for several AMP genes after M. anisopliae and B. subtilis exposures. Therefore, our findings suggest that Relish plays a critical role in inducing the humoral immune response in Drosophila S2 cells, contributing primarily to the response against M. luteus and, to a lesser extent, to the responses against B. subtilis and M. anisopliae .